Total Payments
$3,558
2024 Payments
$474.22
Companies
29
Transactions
212
Medicare Patients
3,957
Medicare Billing
$238,325
Payment Breakdown by Category
Food & Beverage$3,558 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,558 | 212 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $519.96 | 42 | $0 (2024) |
| ABBVIE INC. | $492.34 | 27 | $0 (2022) |
| Amgen Inc. | $487.81 | 23 | $0 (2022) |
| PFIZER INC. | $418.44 | 17 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $291.82 | 23 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $168.06 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $154.29 | 11 | $0 (2024) |
| Lilly USA, LLC | $147.96 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $139.32 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $98.77 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $474.22 | 26 | PFIZER INC. ($165.90) |
| 2023 | $289.20 | 16 | Lilly USA, LLC ($77.90) |
| 2022 | $475.91 | 32 | Novo Nordisk Inc ($132.11) |
| 2021 | $869.90 | 53 | AbbVie Inc. ($312.41) |
| 2020 | $450.77 | 32 | AbbVie Inc. ($89.69) |
| 2019 | $928.39 | 48 | Amgen Inc. ($248.26) |
| 2018 | $69.72 | 5 | Merck Sharp & Dohme Corporation ($37.56) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Biological | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 10/15/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, ABRYSVO | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: VACCINES | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Ethicon US, LLC | Enseal (Device), Echelon Flex, ETHICON | Food and Beverage | In-kind items and services | $54.56 | General |
| Category: Energy | ||||||
| 08/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Insulin Pump | ||||||
| 07/15/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: VACCINES | ||||||
| 06/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, PENBRAYA | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: VACCINES | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), PENBRAYA | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: VACCINES | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,010 | 1,387 | $160,556 | $63,367 |
| 2022 | 30 | 1,026 | 1,454 | $176,501 | $63,919 |
| 2021 | 29 | 987 | 1,465 | $179,747 | $65,640 |
| 2020 | 26 | 934 | 1,299 | $140,894 | $45,398 |
Total Patients
3,957
Total Services
5,605
Medicare Billing
$238,325
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 229 | $54,960 | $18,019 | 32.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $10,585 | $8,180 | 77.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 38 | $15,200 | $5,068 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $5,270 | $4,265 | 80.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 72 | $10,800 | $4,187 | 38.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 63 | $9,450 | $3,873 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 40 | $8,200 | $3,699 | 45.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 42 | $2,940 | $2,881 | 98.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 30 | 31 | $6,820 | $2,755 | 40.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 94 | 157 | $1,570 | $1,319 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 44 | $1,320 | $1,294 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 74 | $3,848 | $1,218 | 31.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 79 | 92 | $6,900 | $1,194 | 17.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 87 | 106 | $7,420 | $1,097 | 14.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 84 | 104 | $2,600 | $791.44 | 30.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $750.00 | $735.00 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 12 | 12 | $1,320 | $703.44 | 53.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 36 | 54 | $1,890 | $514.08 | 27.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 14 | 16 | $1,312 | $464.16 | 35.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 17 | 17 | $935.00 | $321.64 | 34.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 28 | 32 | $3,520 | $274.04 | 7.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 14 | 16 | $1,248 | $236.48 | 18.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 17 | $884.00 | $163.95 | 18.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 24 | 37 | $814.00 | $115.07 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 278 | $66,720 | $22,110 | 33.1% |
About Dr. Christian Zuniga, D.O
Dr. Christian Zuniga, D.O is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1053722355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christian Zuniga, D.O has received a total of $3,558 in payments from pharmaceutical and medical device companies, with $474.22 received in 2024. These payments were reported across 212 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,558).
As a Medicare-enrolled provider, Zuniga has provided services to 3,957 Medicare beneficiaries, totaling 5,605 services with total Medicare billing of $238,325. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 05/08/2014
- Last Updated 04/20/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053722355
Products in Payments
- EVENITY (Biological) $309.21
- LINZESS (Drug) $238.13
- JANUVIA (Drug) $211.81
- EUCRISA (Drug) $185.53
- XIFAXAN (Drug) $168.06
- Rybelsus (Drug) $162.62
- Ozempic (Drug) $153.93
- Vascepa (Drug) $139.32
- PREVNAR 20 (Biological) $118.29
- Saxenda (Drug) $111.68
- MOUNJARO (Drug) $108.98
- Aimovig (Biological) $105.37
- XARELTO (Drug) $98.77
- Yupelri (Drug) $90.06
- REXULTI (Drug) $75.64
- VRAYLAR (Drug) $74.50
- UBRELVY (Drug) $73.51
- Prolia (Biological) $73.23
- Kerendia (Drug) $67.78
- PREVNAR 13 (Biological) $59.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681